Uveal melanoma (UM) is a rare intraocular tumor that, similar to cutaneous melanoma, originates from melanocytes. To gain insights into its genetics, we performed whole genome sequencing at very deep coverage of tumor / control pairs in 33 samples (24 primary and 9 metastases). Genome-wide, the number of coding mutations was rather low (only 17 variants per tumor on average; range: 7-28), thus radically different from cutaneous melanoma, where hundreds of exonic DNA insults are usually detected. Furthermore, no UV light-induced mutational signature was identified. Recurrent coding mutations were found in the known UM drivers GNAQ, GNA11, BAP1, EIF1AX, and SF3B1. Other genes, i.e.
Despite having the very rare incidence of 5-8 new cases per million per year, 1,2 uveal melanoma (UM [MIM: 155720] ) is the most common primary intraocular tumor of the adult.
It develops from melanocytes in the choroid, the ciliary body, or the iris (collectively called the "uvea", one of the inner layers of the eye) and usually metastasizes through the blood stream to the liver. 3, 4 Symptoms include variable and painless visual disturbances, often presenting when the tumor has already reached a considerable mass. Survival and potential therapeutic options depend, among other things, on the presence of specific genetic alterations. 5 While population studies suggest ethnic predisposition, 6,7 environmental factors that are directly involved in the transformation process have not been clearly delineated. For instance, a possible association with UV light exposure has been suggested, [8] [9] [10] [11] but questioned recently by molecular data. 12 Research on UM molecular genetics has been performed mostly by investigating coding mutations or copy number variations detectable by direct sequencing of target genes, karyotype, array-CGH, MLPA, or SNP-array analyses. [13] [14] [15] [16] [17] As a result, mutations at codon 209 of the paralogous oncogenes GNAQ [MIM: 600998] and GNA11 [MIM: 139313] 18, 19 and in the tumor suppressor BAP1 [MIM: 603089] 20 have been identified in the majority of UMs, whereas insults in EIF1AX [MIM: 300186] and SF3B1 [MIM: 605590] or other genes seem to be less frequent, accounting for at most 20% of cases. 12, [21] [22] [23] [24] [25] [26] Moreover, copy gains and losses are common events in this tumor, typically involving chromosome 3 monosomy, 6p gain, and 8q gain. 14, 17 Following whole-genome sequencing of a series of tumor-control pairs, we present here an analytically unbiased and comprehensive assessment of the genetic landscape of UM.
We screened 33 UM samples (24 primary tumors and 9 unrelated metastases, Table   S1 ) and corresponding normal tissue pairs by deep coverage whole-genome sequencing (WGS), using the sequencing platform by Complete Genomics. 27 Written informed consent was obtained from all individuals enrolled in this study, and approval for human subject research was obtained from the Institutional Review Boards of all participating Institutions.
Sequence reads were mapped to the human reference genome, assembly GRch37, and somatic variants in tumors were called by comparison with the matched normal genomes, as previously described. 28 All samples were surgically collected from eye enucleations or resected from liver metastases, allowing very clear post-surgery macroscopic isolation of tumor tissue from the surrounding environment. None of the 33 affected individuals received any treatment prior to primary tumor removal. Average coverage was 112x (range: 102-118) for both tumor and control samples (>96% of the genome was covered 40x or more times), with minimal inter-individual variations (not shown). Mutation calls were performed genome-wide and included single-nucleotide variants (SNVs), copy number variations (CNVs), as well as structural variations (SVs) such as chromosomal rearrangements. CNVs and SVs were assessed by comparing sequence coverage and especially de novo assembly of reads defining novel genetic junctions. 28 Data were extracted from MasterVar files and other relevant matrices by ad hoc Perl, bash, and R scripts, available upon request. Overall, we detected 37,321 SNVs (average per sample: 1,166; range: 576-2,131), 1,584 SVs (average per sample: 50, range: 13-182), and a number of CNVs corresponding to an average of 13.6% of the genome (range: 0.03-33.9%) (Table S2) .
Unsupervised hierarchical clustering of our samples on CNVs revealed four major subgroups associated with mutational and metastatic status, branched two by two ( Figure   1 ). Classes A and B (first branch) involved samples carrying chromosome 3 monosomy (by Fisher test, p-value=4.4x10 -06 ), chr 8q gain (p-value=2.8x10 -09 ), and in some instances chr 8p loss (p-value=3.0x10 -02 ). In addition, class B tumors also had loss of chr 6q (p-value=1.0x10 -03 ). Conversely, classes C and D represented more distinct subtypes with relatively few 5 of 23 chromosomal rearrangements; class C tumor had no major aneuploidies, whereas class D reported gains of the distal part of chr 8q (p-value=2.0x10 -03 ). Seven samples presenting chr 1q gain were scattered across all classes, whereas loss of chr 1p were typical of class A tumors (p-value=5.0x10 -03 ).
Samples with monosomy of chr 3 were also associated (77% of cases) with somatic mutations in the tumor suppressor BAP1, lying on chr 3p21.1, in accordance with Knudson's two-hit model of tumorigenesis. 29 Indeed, BAP1 SNVs included all kinds of somatic events, but mostly mutations leading to premature stop codons and therefore to functional protein knockout ( Figure S1 , Table S3 ). Hallmark driver mutations in the GNAQ and GNA11 paralogues, encoding the components of the alpha subunit of the Gq protein heterotrimer, were present in 100% of the samples examined. They occurred in a perfectly mutually (Splicing Factor 3B, subunit 1), affecting codon 625 (5 cases) and codon 626 (1 case) ( Figure   S1 , Table S3), a previously described hotspot region. 21 Finally, 7 other tumors had mutations impacting the first 10 codons of EIF1AX (Eukaryotic Translation Initiation Factor 1A, XLinked) ( Figure S1 , Table S3 ). 22 Mutations in SF3B1 and EIF1AX seemed to occur in a mutually exclusive pattern and to be enriched classes C and D (p-value=1.6x10 -4 ), with SF3B1 preferentially mutated in class D. Except for one sample, BAP1 mutations were never observed in cases carrying mutations in SF3B1 or EIF1AX (p-value= 1.4x10 -5 ), in agreement with findings from previous literature. 23, 30 Also, consistent with the fact that all of the tumors analyzed harbored variants affecting either GNAQ or GNA11 Gln209, no somatic SNVs were observed in PLCB4 or CYSLTR2, two genes that have been found to be mutated in a mutually exclusive pattern with respect to GNAQ or GNA11 variants. 25, 26 Five (Table S3) . No other nonsynonymous SNVs affecting coding regions of the genome were present in more than two samples. TP53BP1 is a partner of the tumor suppressor protein p53, known to play a crucial role in maintaining genomic integrity as a mediator and effector of homologous recombination in response to double-strand breaks. This protein acts as a molecular scaffold that recruits responsive proteins, in order to repair damaged chromatin 31 and its depletion has been associated with increased cell proliferation. 32 CSMD1 (Cub and Sushi Multiple Domains-1) is a candidate tumor suppressor gene, the hyper-expression of which increased survival in mice with xenografted tumors. 33 Loss of CSMD1 was detected in a large set of cancers, including head and neck, lung, breast and skin primary tumors, 34 and associated with high tumor grade in invasive ductal breast carcinoma. 35 TTC28 (Tetratricopeptide Repeat Domain 28) is a ubiquitous protein, associated with diverse biological functions. Of note, TCC28 plays a critical role in the progress of mitosis and cytokinesis during mammalian cell cycle and its dysfunction was described as a potential component of tumorigenesis and tumor progression. 36,37 DLK2 (Delta-Like 2 homolog) is a transmembrane epidermal growth factor-like protein. It is highly homologous to DLK1, a protein that was found to be present at high levels in gliomas and involved in cell proliferation. 38 Similar to DLK1, DLK2 can bind to NOTCH1, 39 modulating the oncogenic potential of cultured melanoma cells. 40 Finally, KTN1 (Kinectin 1) is a protein of the endoplasmic reticulum membrane that interacts with kinesins. 41, 42 Its role in cancer may be linked to dysregulation of cytoskeletal activity and mitosis. Two of these five genes were previously found to be mutated in UM: a missense in TTC28 was detected in one out 35 samples from a WES screen, 22 while the cBioPortal repository reports a missense mutation in KTN1 in one out of 80 tumors profiled by TCGA. 43, 44 Taken together, our clustering analysis indicates that initial events involve GNAQ or Remarkably, when considering specific levels of 8q amplification detectable by algorithms querying non-coding WGS data for CNVs and aneuploidies, we found a very clear association between metastatic potential and 8q ploidy of 5 copies or more (p-value=8.6x10 -
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with primary tumors (p-value=4.7x10 -3 , Figure 3A) . Similarly, when mutational sets defining tumor sub-classes were considered, a significant association between sub-class B and metastases was identified (Figure 1, p-value=2.0x 10 -2 ).
With respect to metastatic samples, the aneuploidies identified correlated well with those of 66 liver metastases from UM investigated previously, detecting chr 3 monosomy (73%), 8q gain (89%), 6q loss (64%), 1p loss (47%), 8p loss (45%), 1q gain (35%) and 16q loss (32%). 14 Similarly, the identified SNVs matched those on another study on 5 liver metastases. 45 Finally, the identification of a SF3B1 mutation in one metastatic sample from our series is also in line with late-onset metastasis occurring in individuals with SF3B1 mutations. 23 Mutations targeting BAP1 are one of the genetic landmarks of UM 20 (Figure S2 ), confirming that, compared to both cutaneous and conjunctival melanomas, which also originate from melanocytes, UM follows a different oncogenic pathway, characterized by significantly fewer mutations. 47, 48 In addition, we failed to identify any statistically relevant non-coding SNVs for tumor-specific sites that were present in four samples or more, suggesting the absence of common regulatory variants in the landscape of these tumors, at least in our cohort.
Another difference between UM and cutaneous and conjunctival melanomas involved its mutational spectrum ( Figure 5 ). Analysis of all coding and non-coding somatic single-nucleotide substitutions (SNSs) from our series showed the clear absence of an UVinduced mutation signature. This particular spectrum results from sunlight-driven formation of pyrimidine dimers on the DNA 49 and is found in both cutaneous and conjunctival melanomas. 47 50, 51 Conversely, the UM mutational spectrum was remarkably similar across all PUMs and MUMs and resembled that of apparently unrelated tumors, such as clear cell renal carcinoma, thyroid tumor, and glioblastoma ( Figure 6 ). Notably, despite a different cellular origin, UM shares with these tumors recurrent genetic modifications; BAP1 mutations and chr 3 monosomy are frequently seen in clear cell renal carcinoma, 52 while hotspot mutations in the first codons of EIF1AX are recurrent in papillary thyroid carcinoma. 53 Analysis of all specific SNS types along with composition of the flanking bases allowed determining specific mutational signatures for UM, according to the classification of Alexandrov et al. 54 Our samples appeared to be enriched for signatures 12 or 16 (55% of the score), signature 1B (25%), and signature 6 (20%) ( Figure 5B ). Signature 1B corresponds to a rather ubiquitous pattern in cancer, resulting from the spontaneous deamination of 5-methyl-cytosine, which in turn is thought to correlate with the process of aging. 54, 55 Conversely, signatures 12/16 and 6 are associated with defects in nucleotide excision repair and DNA mismatch repair, respectively.
A more global approach, considering the intersection between the SNVs detected in our series and the most frequently mutated genes in cancer (TCGA PANCAN list) 56 also revealed a minimal overlap, limited to BAP1 and SF3B1 ( Figure S4) .
A non-negligible number of structural variants (SVs) such as deletions, duplications, inversions, or inter and intra chromosomal rearrangements were also observed ( Figure S5 ).
Only a few of these events were recurrent, indicating the absence of major common drivers constituted by genetic events involving large parts of the genome. Among these, however, there were three inter-chromosomal events that were present in at least two individuals (Table S5) . Although these translocations impacted roughly the same genomic areas, highlighting possible hotspot regions in UM genome, they neither targeted the same genes nor defined a specific tumor sub-category. Of note, one individual (PUM5) appeared to harbor a higher number of interchromosomal events and SVs than the average value of the other cases ( Figure S5 ). Notably, this individual was also an outlier of our clustering analysis (Figure 1 ). However, neither the medical history nor tumor pathology revealed any uncommon feature, compared to the rest of the cohort.
Amplification of chr 8q is a well-known and important feature of UM. 17, 57, 58 Levels of chr 8q amplification seem to define prognostic status and metastatic potential in UM and differentiate class C from D (Figures 1 and 2) . However, the molecular bases for this phenomenon are not known. One possible explanation is that the amplification is driven by the MYC oncogene [MIM: 190080] , which lies in this region. 59 By comparing the pattern of chr 8q amplification in our samples, we determined the minimal region of overlap, involving a 2.3 Mb fragment towards its telomeric site (chr8:126,404,000-128,682,000). were expressed in our UM samples, but no statistically significant correlation between their expression levels and 8q amplification or tumor class could be detected. The same held true for the MYC transcript, suggesting that none of these genes play a key role in UM pathogenesis ( Figures S6-S7 ).
By using a WGS-based, untargeted approach to investigate the genetic components of UM, we had the unique opportunity of assessing its genomic landscape as a whole, from single nucleotide variants to interchromosomal rearrangements, providing the bases for future functional studies that go beyond the scope of our analysis. The global picture emerging from our work indicates that, genetically, UM is a relatively atypical tumor, mostly in virtue of the paucity of somatic events that characterize it. Driver mutations are very few and are confined to a relatively low number of genes, such as BAP1, GNAQ and GNA11.
Other genes, including those that were identified in this study, may have a role in tumorigenesis, but they are nonetheless present in a small fraction of the tumors studied.
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